Dr Paul Brand Centre for Hand Surgery, Leprosy Reconstructive Surgery and Peripheral Nerve Surgery, Department of Hand Surgery, Christian Medical College Hospital, Vellore, Tamil Nadu, India.
Department of Pathology, Christian Medical College, Ida Scudder Road, Vellore, Tamil Nadu, India.
Foot Ankle Int. 2024 Mar;45(3):243-251. doi: 10.1177/10711007231217283. Epub 2024 Feb 9.
Glomus tumors are uncommon tumors and their occurrence in the foot is even less common. Glomus tumors of the toes are often missed, causing delays in diagnosis and treatment. We report an ambispective observational study of glomus tumors of the toes that were treated at our institution.
We reviewed the records of all the patients who underwent excision of toe glomus tumors in our department from January 2010 to September 2022. The follow-up data were collected from the outpatient records and by telephonic interview. Single Assessment Numeric Evaluation (SANE) score, Foot and Ankle Outcome Score (FAOS), and the Foot Function Index (FFI) were collected.
Out of all the patients treated for glomus tumors, we found that 7 patients had glomus tumors of the toes. Of the 7 patients, 6 were women and 1 was a male. The mean follow-up of our patients was 66.4 months (range, 7-109 months). Of the 7 patients, 1 presented with recurrent glomus tumor 30 months following the primary operation, for which she underwent excision again, after which she was symptom free. Another patient who developed recurrent symptoms on telephonic interview refused any further treatment. Among the 6 patients who were symptom-free at follow-up (including the patient who underwent excision for the recurrent tumor), the median SANE score, and FFI were 99.5 (IQR, 96-100) and 0.5 (IQR, 0-2) respectively. The mean FAOS was 96 (SD, 3.3).
Surgical excision of the subungual toe glomus tumors can be curative. Recurrence of toe glomus tumors was noted in 2 patients (29%), one of whom refused further surgery. Re-excision in the other patient resulted in complete resolution of symptoms.
Level III, ambispective observational study.
血管球瘤是一种少见的肿瘤，发生在足部者更为少见。足部的血管球瘤常被漏诊，导致诊断和治疗延误。我们报告了在我院治疗的足部趾血管球瘤的前瞻性和回顾性观察性研究结果。
我们回顾了 2010 年 1 月至 2022 年 9 月期间在我院接受趾血管球瘤切除术的所有患者的病历资料。通过门诊记录和电话访谈收集随访数据。收集了单一评估数字评估（SANE）评分、足踝结局评分（FAOS）和足部功能指数（FFI）。
在所治疗的血管球瘤患者中，我们发现有 7 例为趾血管球瘤。7 例患者中，女性 6 例，男性 1 例。患者的平均随访时间为 66.4 个月（7-109 个月）。7 例患者中，1 例在初次手术后 30 个月出现复发性血管球瘤，再次行切除术，术后症状消失。另 1 例在电话访谈中出现复发性症状的患者拒绝进一步治疗。在 6 例随访时无症状的患者（包括因复发性肿瘤而接受切除术的患者）中，中位数 SANE 评分和 FFI 分别为 99.5（IQR，96-100）和 0.5（IQR，0-2），FAOS 平均为 96（SD，3.3）。
趾下血管球瘤的手术切除可以达到治愈效果。2 例（29%）患者出现趾血管球瘤复发，其中 1 例拒绝进一步手术，另 1 例再次切除后症状完全缓解。
III 级，前瞻性和回顾性观察性研究。
